Perfil
David P.
Nowotnik is currently a Director at TheraTarget, Inc. He was previously a Senior Director-Product Development at Guilford Pharmaceuticals, Inc. from 1994 to 1998.
He also held the position of Senior Vice President-Research & Development at Abeona Therapeutics, Inc. Dr. Nowotnik earned a doctorate degree from the University of London.
Cargos activos de David P. Nowotnik
| Empresas | Cargo | Inicio |
|---|---|---|
TheraTarget, Inc.
TheraTarget, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical drug delivery company which develops polymer-drug conjugates | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de David P. Nowotnik.
| Empresas | Cargo | Fin |
|---|---|---|
Guilford Pharmaceuticals, Inc.
Guilford Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs used to treat neurological diseases | Corporate Officer/Principal | 01/01/1998 |
| ABEONA THERAPEUTICS INC. | Corporate Officer/Principal | - |
Formación de David P. Nowotnik.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
Abeona Therapeutics, Inc.
Abeona Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes cell and gene therapies for life-threatening rare genetic diseases | Health Technology |
Guilford Pharmaceuticals, Inc.
Guilford Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs used to treat neurological diseases | Health Technology |
University of London
University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TheraTarget, Inc.
TheraTarget, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical drug delivery company which develops polymer-drug conjugates | Health Technology |
- Bolsa de valores
- Insiders
- David P. Nowotnik
















